Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT06760052
Recruiting
Longitudinal Data Registry of Plasma Cell Dyscrasia
Not applicable · China · 1 site
Registry update: 3 Aug 2026
NCT05651932
Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Phase 1 · Canada, Spain, France, United States · 29 sites
Registry update: 22 Oct 2026
NCT05737732
Recruiting
The Ambient Light Multiple Myeloma Study
Not applicable · United States · 2 sites
Registry update: 12 Jun 2026
NCT05565807
Recruiting
Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
Phase 1/2 · China · 4 sites
Registry update: 15 Aug 2025
NCT05722418
Recruiting
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Phase 1 · United States · 16 sites
Registry update: 25 Sept 2025
NCT05665140
Recruiting
Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
Phase 2/3 · Germany · 23 sites
Registry update: 11 Dec 2024
Conflicting statuses (not updated in the registry for 23 months)
NCT05735704
Recruiting
Early Detection and Screening of Hematological Malignancies - SANGUINE
Not applicable · Czechia, Greece, Israel, Lithuania · 4 sites
Registry update: 15 Oct 2026
NCT03633955
Recruiting
Pilot Imaging Study of Leukemia
Phase 1 · United States · 3 sites
Registry update: 23 Apr 2026
NCT05344833
Recruiting
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
Phase 2 · United States · 2 sites
Registry update: 28 Aug 2026
NCT05686447
Recruiting
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Not applicable · China · 1 site
Registry update: 6 Apr 2025
NCT05646576
Recruiting
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Not applicable · United States · 1 site
Registry update: 21 Apr 2026
NCT05645107
Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Phase 3 · Bulgaria, Croatia, Hungary, Poland, Romania, Serbia, United States · 61 sites
Registry update: 30 Sept 2026
NCT06237803
Recruiting
European Myeloma Network (EMN) Sample Project
Not applicable · Austria, Australia, Belgium, Switzerland, Czechia, Greece, Ireland, Italy, Portugal, Serbia · 41 sites
Registry update: 3 Dec 2025
NCT04935684
Recruiting
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · France · 20 sites
Registry update: 21 Sept 2026
NCT07111884
Recruiting
GMMG Multiple Myeloma Registry
Not applicable · Germany · 35 sites
Registry update: 8 Aug 2025
NCT06209606
Recruiting
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
Early phase 1 · United States · 1 site
Registry update: 17 Dec 2024
NCT05091372
Recruiting
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
Phase 2 · United States · 1 site
Registry update: 2 Nov 2026
NCT05695508
Recruiting
GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
Phase 2 · Germany · 11 sites
Registry update: 24 Dec 2025
NCT05678621
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/3 · Australia · 7 sites
Registry update: 19 Apr 2024
NCT05640843
Recruiting
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Not applicable · United States · 8 sites
Registry update: 16 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.